Hazard and risk assessment strategies for nanoparticle exposures: How far have we come in the past 10 years?

F1000Research

Volumn 7, Issue , 2018, Pages

  Warheit, David B ^a  

^a CHEMOURS COMPANY   (United States)

Author keywords

Nanoparticle exposures; Nanosafety; Nanotechnology

Indexed keywords

MULTI WALLED NANOTUBE; NANOMATERIAL; NANOPARTICLE; SINGLE WALLED NANOTUBE;

ANIMAL EXPERIMENT; CONTROLLED STUDY; ENVIRONMENTAL HEALTH; EUROPEAN UNION; FEMALE; GENOTOXICITY; HAZARD ASSESSMENT; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG LAVAGE; MALE; NANOTECHNOLOGY; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PARTICLE SIZE; PUBLICATION; RAT; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; TOXICITY TESTING; UNITED STATES; WORK ENVIRONMENT; WORKSHOP;

EID: 85044783055     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.12691.1     Document Type: Review

References (20)

1. Warheit DB Sayes CM Reed KL: Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks. Pharmacol Ther. 2008;120(1):35-42. 18703086 10.1016/j.pharmthera.2008.07.001
2. Maynard AD Aitken RJ Butz T: Safe handling of nanotechnology. Nature. 2006;444(7117):267-9. 17108940 10.1038/444267a
3. Maynard AD Aitken RJ: 'Safe handling of nanotechnology' ten years on. Nat Nanotechnol. 2016;11(12):998-1000. 27920442 10.1038/nnano.2016.270 F1000 Recommendation
4. Warheit DB Borm PJ Hennes C: Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop. Inhal Toxicol. 2007;19(8):631-43. 17510836 10.1080/08958370701353080
5. Stone V Pozzi-Mucelli S Tran L: ITS-NANO--prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy. Part Fibre Toxicol. 2014;11:9. 24521051 10.1186/1743-8977-11-9 3931673 F1000 Recommendation
6. Johnston H Pojana G Zuin S: Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges. Crit Rev Toxicol. 2013;43(1):1-20. 23126553 10.3109/10408444.2012.738187 F1000 Recommendation
7. Kermanizadeh A Gosens I MacCalman L: A Multilaboratory Toxicological Assessment of a Panel of 10 Engineered Nanomaterials to Human Health--ENPRA Project--The Highlights, Limitations, and Current and Future Challenges. J Toxicol Environ Health B Crit Rev. 2016;19(1):1-28. 27030582 10.1080/10937404.2015.1126210 F1000 Recommendation
8. Farcal L Torres Andón F Di Cristo L: Comprehensive In Vitro Toxicity Testing of a Panel of Representative Oxide Nanomaterials: First Steps towards an Intelligent Testing Strategy. PLoS One. 2015;10(5):e0127174. 25996496 10.1371/journal.pone.0127174 4440714 F1000 Recommendation
9. Clippinger AJ Ahluwalia A Allen D: Expert consensus on an in vitro approach to assess pulmonary fibrogenic potential of aerosolized nanomaterials. Arch Toxicol. 2016;90(7):1769-83. 27121469 10.1007/s00204-016-1717-8 4894935 F1000 Recommendation
10. National Research Council: Research Progress on Environmental, Health, and Safety Aspects of Engineered Nanomaterials. National Academies Press, Washington, D.C.2013. Reference Source
11. Hussain SM Warheit DB Ng SP: At the Crossroads of Nanotoxicology in vitro: Past Achievements and Current Challenges. Toxicol Sci. 2015;147(1):5-16. 26310852 10.1093/toxsci/kfv106
12. Geiser M Jeannet N Fierz M: Evaluating Adverse Effects of Inhaled Nanoparticles by Realistic In Vitro Technology. Nanomaterials (Basel). 2017;7(2): pii: E49. 28336883 10.3390/nano7020049 5333034 F1000 Recommendation
13. Fytianos K Drasler B Blank F: Current in vitro approaches to assess nanoparticle interactions with lung cells. Nanomedicine (Lond). 2016;11(18):2457-69. 27529369 10.2217/nnm-2016-0199 F1000 Recommendation
14. Warheit DB: How to measure hazards/risks following exposures to nanoscale or pigment-grade titanium dioxide particles. Toxicol Lett. 2013;220(2):193-204. 23603385 10.1016/j.toxlet.2013.04.002
15. Warheit DB Hoke RA Finlay C: Development of a base set of toxicity tests using ultrafine TiO 2 particles as a component of nanoparticle risk management. Toxicol Lett. 2007;171(3):99-110. 17566673 10.1016/j.toxlet.2007.04.008
16. Delorme MP Muro Y Arai T: Ninety-day inhalation toxicity study with a vapor grown carbon nanofiber in rats. Toxicol Sci. 2012;128(2):449-60. 22581831 10.1093/toxsci/kfs172
17. Krug HF: Nanosafety research--are we on the right track? Angew Chem Int Ed Engl. 2014;53(46):12304-19. 25302857 10.1002/anie.201403367 F1000 Recommendation
18. Kreyling WG Holzwarth U Haberl N: Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats: Part 1. Nanotoxicology. 2017;11(4):434-42. 28290717 10.1080/17435390.2017.1306892 F1000 Recommendation
19. Kreyling WG Holzwarth U Schleh C: Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats: Part 2. Nanotoxicology. 2017;11(4):443-53. 28290734 10.1080/17435390.2017.1306893 F1000 Recommendation
20. Kreyling WG Holzwarth U Haberl N: Quantitative biokinetics of titanium dioxide nanoparticles after intratracheal instillation in rats: Part 3. Nanotoxicology. 2017;11(4):454-64. 28290735 10.1080/17435390.2017.1306894 F1000 Recommendation